PrecisemAb Biotech received the First Prize in the Company Category at the 9th Startup Star Pitch Competition, highlighting the team’s continued achievements in innovative drug development.
Looking back on last year, despite the unfortunate passing of our founder, Vice President Cheng Tien-Lu, the PrecisemAb team did not slow down. Instead, we remained steadfast and committed, further strengthening our technologies and advancing the development of our antibody therapeutics.
This recognition not only affirms our dedication to our mission but also symbolizes our ability to grow through challenges and move toward even more impactful milestones.
Online News Link：
